Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Long-Term Investments (2023 - 2025)

Cyclerion Therapeutics (CYCN) has disclosed Long-Term Investments for 3 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • For Q3 2025, Long-Term Investments changed 0.0% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $5.4 million, changed 0.0%, while the annual FY2024 figure was $5.4 million, 0.0% changed from the prior year.
  • Long-Term Investments hit $5.4 million in Q3 2025 for Cyclerion Therapeutics, roughly flat from $5.4 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $5.4 million in Q3 2023 and bottomed at $5.4 million in Q3 2023.
  • Average Long-Term Investments over 3 years is $5.4 million, with a median of $5.4 million recorded in 2023.
  • On a YoY basis, Long-Term Investments climbed as much as 0.0% in 2024 and fell as far as 0.0% in 2024.
  • Cyclerion Therapeutics' Long-Term Investments stood at $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $5.4 million, $5.4 million, and $5.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.